|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 1,508
<SECURITIES> 0
<RECEIVABLES> 5,552
<ALLOWANCES> 266
<INVENTORY> 2,777
<CURRENT-ASSETS> 11,531
<PP&E> 12,045
<DEPRECIATION> 5,129
<TOTAL-ASSETS> 26,496
<CURRENT-LIABILITIES> 5,952
<BONDS> 5,003<F1>
0
263
<COMMON> 2,937
<OTHER-SE> 8,996
<TOTAL-LIABILITY-AND-EQUITY> 26,496
<SALES> 13,608
<TOTAL-REVENUES> 13,608
<CGS> 4,210
<TOTAL-COSTS> 4,210
<OTHER-EXPENSES> 2,090<F2>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 303
<INCOME-PRETAX> 1,091
<INCOME-TAX> 340
<INCOME-CONTINUING> 751
<DISCONTINUED> (27)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 724
<EPS-BASIC> 0.56
<EPS-DILUTED> 0.55
<FN>
<F1> Includes guarantee of ESOP dept.
<F2> Only includes R&D expense.
</FN>
</TABLE>
|
|